Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Octocog alfa sucrose formulation - Bayer HealthCare

Drug Profile

Octocog alfa sucrose formulation - Bayer HealthCare

Alternative Names: BAY 81-8973; BAY-14-2222; Factor VIII sucrose formulation - Bayer; Helixate FS; Helixate NexGen; Iblias; Kogenate Bayer; Kogenate FS; Kogenate PF; Kogenate SF; Kovaltry; rFVIII FS

Latest Information Update: 30 Jul 2018

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Bayer HealthCare
  • Developer Bayer HealthCare; CSL Behring
  • Class Antihaemorrhagics; Blood coagulation factors; Coagulants; Recombinant proteins
  • Mechanism of Action Blood coagulation factor replacements; Factor X stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    Yes - Haemophilia A
  • New Molecular Entity No

Highest Development Phases

  • Marketed Haemophilia A

Most Recent Events

  • 24 Jul 2018 Registered for Haemophilia A (In adolescents, Prevention, In adults) in China (IV)
  • 24 Jul 2018 Registered for Haemophilia A (In children, In adults) in China (IV)
  • 29 Jun 2016 Launched for Haemophilia A in Japan (IV) before June 2016 (PMDA website)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top